Smith & Nephew Plc Director/PDMR Shareholding (6133S)
18 March 2021 - 2:30AM
UK Regulatory
TIDMSN.
RNS Number : 6133S
Smith & Nephew Plc
17 March 2021
SMITH & NEPHEW PLC
17 March 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM.
Following the announcement on 9 March 2021, regarding the awards
made under the Smith & Nephew Global Share Plan 2020 of US$0.20
ordinary shares (the "Shares") in Smith & Nephew plc (the
"Company"), those share awards vested on 16 March 2021.
1. FINAL VESTING ON 16 MARCH 2021 OF SUPPLEMENTARY AWARDS
GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020 FOR THE
2018 PERFORMANCE SHARE PROGRAMME AWARDS:
The awards were granted under the Global Share Plan 2020 on 8
March 2021. A number of Shares were sold to cover taxation
obligations arising on the vesting of the awards.
The following relates to all individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
-------------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
-------------------------------------------------
LEI 213800ZTMDN8S67S1H61
-------------------------------------------------
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
Description of the Smith & Nephew plc ordinary shares of
financial instrument, USD 0.20 each
type of instrument
-------------------------------------------------
Identification code ISIN: GB0009223206
-------------------------------------------------
Nature of the transaction Final vesting on 16 March 2021 of Supplementary
Awards granted under the Smith & Nephew
Global Share Plan 2020 for the 2018 Performance
Share Programme awards .
-------------------------------------------------
Date of Transaction 2021 - 03 - 16
-------------------------------------------------
Place of Transaction London Stock Exchange (XLON)
-------------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Name Price Aggregated the transaction the transaction
(Position) Status (GBP) Volume information * *
3,740
(of which 84,165.76313
Bradley Cannon 1,665 ordinary
(President were sold shares (including
Sports Medicine and 2,075 N/A Single 2,101.64550
& ENT) PDMR 14.0000 retained) Transaction in ADS') 0.00951%
-------- -------- --------------- ------------- ------------------- -----------------
Phil Cowdy 1,781
(Chief Business (of which
Development 841 were 45,298.19975
& Corporate sold and N/A Single ordinary
Affairs Officer) PDMR 14.0000 940 retained) Transaction shares 0.00512%
-------- -------- --------------- ------------- ------------------- -----------------
2,848
(of which 106,816.00000
1,125 ordinary
Elga Lohler were sold shares (including
(Chief HR and 1,723 N/A Single 3,015.00000
Officer) PDMR 14.0000 retained) Transaction in ADS') 0.01207%
-------- -------- --------------- ------------- ------------------- -----------------
2,823
Catheryn (of which 81,517.23565
O'Rourke 963 were ordinary
(Chief Legal sold and shares (including
& Compliance 1,860 N/A Single 5,818.25734
Officer) PDMR 14.0000 retained) Transaction in ADS') 0.00921%
-------- -------- --------------- ------------- ------------------- -----------------
3,207
(of which
Vasant Padmanabhan 1,089
(President were sold 64,620.00000
Research and 2,118 N/A Single ordinary
& Development) PDMR 14.0000 retained) Transaction shares 0.00730%
-------- -------- --------------- ------------- ------------------- -----------------
1,255
(of which
Susan Swabey 592 were 49,225.83952
(Company sold and N/A Single ordinary
Secretary) PDMR 14.0000 663 retained) Transaction shares 0.00556%
-------- -------- --------------- ------------- ------------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFLEVTIDLIL
(END) Dow Jones Newswires
March 17, 2021 11:30 ET (15:30 GMT)
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Apr 2024 to May 2024
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From May 2023 to May 2024